Matrix Metalloproteinase-9 Contributes to Choroidal Neovascularization
- 1 October 2002
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 161 (4) , 1247-1253
- https://doi.org/10.1016/s0002-9440(10)64401-x
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasisTrends in Cell Biology, 2001
- Influence of plasminogen activator inhibitor type 1 on choroidal neovascularizationThe FASEB Journal, 2001
- Intrachoroidal Neovascularization in Transgenic Mice Overexpressing Vascular Endothelial Growth Factor in the Retinal Pigment EpitheliumThe American Journal of Pathology, 2001
- Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathyBritish Journal of Ophthalmology, 2000
- Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarctionJournal of Clinical Investigation, 2000
- Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularizationCurrent Eye Research, 2000
- Targeted Disruption of the FGF2 Gene Does Not Prevent Choroidal Neovascularization in a Murine ModelThe American Journal of Pathology, 1998
- Macrophage-Derived Metalloelastase Is Responsible for the Generation of Angiostatin in Lewis Lung CarcinomaCell, 1997
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophyNature Genetics, 1994